266 related articles for article (PubMed ID: 12541134)
1. Tumour-specific activation of the sodium/iodide symporter gene under control of the glucose transporter gene 1 promoter (GTI-1.3).
Sieger S; Jiang S; Schönsiegel F; Eskerski H; Kübler W; Altmann A; Haberkorn U
Eur J Nucl Med Mol Imaging; 2003 May; 30(5):748-56. PubMed ID: 12541134
[TBL] [Abstract][Full Text] [Related]
2. Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells.
Haberkorn U; Henze M; Altmann A; Jiang S; Morr I; Mahmut M; Peschke P; Kübler W; Debus J; Eisenhut M
J Nucl Med; 2001 Feb; 42(2):317-25. PubMed ID: 11216532
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy with sodium/iodide symporter in hepatocarcinoma.
Haberkorn U
Exp Clin Endocrinol Diabetes; 2001; 109(1):60-2. PubMed ID: 11573143
[TBL] [Abstract][Full Text] [Related]
4. Iodide kinetics and dosimetry in vivo after transfer of the human sodium iodide symporter gene in rat thyroid carcinoma cells.
Haberkorn U; Beuter P; Kübler W; Eskerski H; Eisenhut M; Kinscherf R; Zitzmann S; Strauss LG; Dimitrakopoulou-Strauss A; Altmann A
J Nucl Med; 2004 May; 45(5):827-33. PubMed ID: 15136633
[TBL] [Abstract][Full Text] [Related]
5. Radioiodine therapy of hepatoma using targeted transfer of the human sodium/iodide symporter gene.
Chen L; Altmann A; Mier W; Eskerski H; Leotta K; Guo L; Zhu R; Haberkorn U
J Nucl Med; 2006 May; 47(5):854-62. PubMed ID: 16644756
[TBL] [Abstract][Full Text] [Related]
6. Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma.
Altmann A; Kissel M; Zitzmann S; Kübler W; Mahmut M; Peschke P; Haberkorn U
J Nucl Med; 2003 Jun; 44(6):973-80. PubMed ID: 12791828
[TBL] [Abstract][Full Text] [Related]
7. Enhanced iodide transport after transfer of the human sodium iodide symporter gene is associated with lack of retention and low absorbed dose.
Haberkorn U; Kinscherf R; Kissel M; Kübler W; Mahmut M; Sieger S; Eisenhut M; Peschke P; Altmann A
Gene Ther; 2003 May; 10(9):774-80. PubMed ID: 12704416
[TBL] [Abstract][Full Text] [Related]
8. 99mTc-pertechnetate uptake in hepatoma cells due to tissue-specific human sodium iodide symporter gene expression.
Chen L; Altman A; Mier W; Lu H; Zhu R; Haberkorn U
Nucl Med Biol; 2006 May; 33(4):575-80. PubMed ID: 16720251
[TBL] [Abstract][Full Text] [Related]
9. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.
Kakinuma H; Bergert ER; Spitzweg C; Cheville JC; Lieber MM; Morris JC
Cancer Res; 2003 Nov; 63(22):7840-4. PubMed ID: 14633711
[TBL] [Abstract][Full Text] [Related]
10. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
[TBL] [Abstract][Full Text] [Related]
11. Specific activation of sodium iodide symporter gene in hepatoma using alpha-fetoprotein promoter combined with hepatitis B virus enhancer (EIIAPA).
Liu RS; Hsieh YJ; Ke CC; Chen FD; Hwu L; Wang FH; Hwang JJ; Chi CW; Lee CH; Yeh SH
Anticancer Res; 2009 Jan; 29(1):211-21. PubMed ID: 19331152
[TBL] [Abstract][Full Text] [Related]
12. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
[TBL] [Abstract][Full Text] [Related]
13. Sodium butyrate enhances the expression of baculovirus-mediated sodium/iodide symporter gene in A549 lung adenocarcinoma cells.
Guo R; Zhang Y; Liang S; Xu H; Zhang M; Li B
Nucl Med Commun; 2010 Oct; 31(10):916-21. PubMed ID: 20683361
[TBL] [Abstract][Full Text] [Related]
14. Codon-optimized human sodium iodide symporter (opt-hNIS) as a sensitive reporter and efficient therapeutic gene.
Kim YH; Youn H; Na J; Hong KJ; Kang KW; Lee DS; Chung JK
Theranostics; 2015; 5(1):86-96. PubMed ID: 25553100
[TBL] [Abstract][Full Text] [Related]
15. Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells.
Li W; Tan J; Wang P; Wu P
Cancer Biother Radiopharm; 2011 Aug; 26(4):443-51. PubMed ID: 21797672
[TBL] [Abstract][Full Text] [Related]
16. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
Ma XJ; Huang R; Kuang AR
Cancer Invest; 2009 Jul; 27(6):673-81. PubMed ID: 19241193
[TBL] [Abstract][Full Text] [Related]
17. Effects of Pax8 and TTF-1 thyroid transcription factor gene transfer in hepatoma cells: imaging of functional protein-protein interaction and iodide uptake.
Altmann A; Schulz RB; Glensch G; Eskerski H; Zitzmann S; Eisenhut M; Haberkorn U
J Nucl Med; 2005 May; 46(5):831-9. PubMed ID: 15872358
[TBL] [Abstract][Full Text] [Related]
18. Tumor-targeted radionuclide imaging and therapy based on human sodium iodide symporter gene driven by a modified telomerase reverse transcriptase promoter.
Kim SH; Chung HK; Kang JH; Kim KI; Jeon YH; Jin YN; Yun CO; Chung JK
Hum Gene Ther; 2008 Sep; 19(9):951-7. PubMed ID: 18810799
[TBL] [Abstract][Full Text] [Related]
19. Sodium-iodine symporter gene expression controlled by the EGR-1 promoter: biodistribution, imaging and in vitro radionuclide therapy with Na(131)I.
Tang J; Wang X; Xu Y; Shi Y; Liu Z; Yang Y
Technol Cancer Res Treat; 2015 Feb; 14(1):61-9. PubMed ID: 24354753
[TBL] [Abstract][Full Text] [Related]
20. In vivo long-term imaging and radioiodine therapy by sodium-iodide symporter gene expression using a lentiviral system containing ubiquitin C promoter.
Kim HJ; Jeon YH; Kang JH; Lee YJ; Kim KI; Chung HK; Jeong JM; Lee DS; Lee MC; Chung JK
Cancer Biol Ther; 2007 Jul; 6(7):1130-5. PubMed ID: 17611400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]